ng-nitroarginine methyl ester and Granulocytic Leukemia, Chronic

ng-nitroarginine methyl ester has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Beyer, AM; Derayunan, A; Durand, MJ; Hader, SN; McIntosh, JJ; Zinkevich, N	1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Granulocytic Leukemia, Chronic

Article	Year
BCR-ABL tyrosine kinase inhibitors promote pathological changes in dilator phenotype in the human microvasculature. Microcirculation (New York, N.Y. : 1994), 2020, Volume: 27, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Arterioles; Cardiotonic Agents; Catalase; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Humans; Hydrogen Peroxide; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Microvessels; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Polyethylene Glycols; Protein Kinase Inhibitors; Pyrimidines; Vasodilation	2020

Article

Year

BCR-ABL tyrosine kinase inhibitors promote pathological changes in dilator phenotype in the human microvasculature.

Microcirculation (New York, N.Y. : 1994), 2020, Volume: 27, Issue:7

Topics: Adult; Aged; Antineoplastic Agents; Arterioles; Cardiotonic Agents; Catalase; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Humans; Hydrogen Peroxide; Imatinib Mesylate; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Microvessels; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Polyethylene Glycols; Protein Kinase Inhibitors; Pyrimidines; Vasodilation

2020